Forum | Friends of Cancer Research

You are here


Molecularly Targeted Therapies in Pediatric Cancer


To access a meeting recap of this archived event, please Click HERE.


A Blueprint for Breakthrough – Charting the Course for Precision Medicine

A Blueprint for Breakthrough – Charting the Course for Precision Medicine

September 13, 2017
Marriott Marquis Hotel

 901 Massachusetts Ave NW, Washington, DC 20001


Friends and Parker Institute for Cancer Immunotherapy Summit: Optimizing the Use of Immunotherapy


Friends of Cancer Research and the Parker Institute for Cancer Immunotherapy convened a roundtable discussion on October 5, 2016, to discuss strategies to optimize the use of immunotherapy in cancer. Leading experts in the field shared their perspective on the state of the field and strategies to address current research questions and evidence gaps.


Immuno-Oncology Working Group Meeting

Friends of Cancer Research, Pfizer, and EMD Serono, working together with scientific, clinical, patient, policy and industry leaders, aimed to develop an I-O strategic policy plan to accelerate progress across multiple oncology disease states.

A Blueprint for Breakthrough: Exploring Utility of Real World Evidence (RWE)

Exploring Use of Real World Evidence in Clinical Trials: A Recap from the 2016 Blueprint for Breakthrough Forum

Enhancing Patient Input and Regulatory Innovation

A Friends of Cancer Research roundtable with:

Dr. Robert Califf

Deputy Commissioner for Medical Products and Tobacco

U.S. Food and Drug Administration


Tuesday May 19, 2015 – 9:00am – 12:00pm